[德国风湿病学会关于肿瘤坏死因子抑制活性物质治疗炎症性疾病的修订建议] - Suppr

Suppr

超能文献

[Revised recommendations of the Deutsche Gesellschaft für Rheumatologie on therapy with tumor necrosis factor-inhibiting active substances on inflammatory diseases].

作者信息

Manger B

机构信息

Medinizische Klinik III, Krankenhausstr. 12, 91054 Erlangen.

出版信息

Z Rheumatol. 2002 Dec;61(6):694-7. doi: 10.1007/s00393-002-0451-1.

DOI:10.1007/s00393-002-0451-1

PMID:12491133

Abstract

摘要

相似文献

[Revised recommendations of the Deutsche Gesellschaft für Rheumatologie on therapy with tumor necrosis factor-inhibiting active substances on inflammatory diseases].

Z Rheumatol. 2002 Dec;61(6):694-7. doi: 10.1007/s00393-002-0451-1.

[The off-label-prescription of TNF-alpha blocking agents for spondyloarthropathies in the context of recent statement by a German federal court].

Z Rheumatol. 2002 Dec;61(6):688-93. doi: 10.1007/s00393-002-0450-2.

Clinical inquiries. Are DMARDs effective for rheumatologic diseases besides rheumatoid arthritis?

J Fam Pract. 2007 Nov;56(11):933-4, 937.

Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists.

Am J Med. 2005 May;118(5):552-6. doi: 10.1016/j.amjmed.2005.01.028.

[Revision of the recommendations of the Commission on Pharmacotherapy of the German society for Rheumatology. Therapy with tumour necrosis factor blockers for inflammatory rheumatic illnesses].

Z Rheumatol. 2007 Feb;66(1):72-5. doi: 10.1007/s00393-006-0132-6.

[Recommendations of the Deutschen Gesellschaft für Rheumatologie on therapy of rheumatoid arthritis with the interleukin-1-receptor-antagonist Akakinra (KINERET)].

Z Rheumatol. 2002 Dec;61(6):698-700. doi: 10.1007/s00393-002-0452-0.

[New biological therapeutic options for the treatment of RE: inhibition of costimulatory molecules and blockade of Interleukin-6-interaction].

Z Rheumatol. 2003 Oct;62(5):433-8. doi: 10.1007/s00393-003-0547-2.

Etanercept (Enbrel) -- an update.

Skin Therapy Lett. 2004;9(10):1-4, 9.

[TNF-alpha inhibitors].

Rev Prat. 2003 Nov 30;53(18):1989-90.

Vitaxin applied molecular evolution.

Curr Opin Investig Drugs. 2000 Oct;1(2):199-203.

引用本文的文献

[Biologics for treatment of juvenile idiopathic arthritis. Consensus statement of the 7th Wörlitzer Expertengespräche 2004 for the German Arbeitsgemeinschaft Kinder- und Jugendrheumatologie].

Z Rheumatol. 2006 Mar;65(2):152-6, 158. doi: 10.1007/s00393-005-0002-7.

[Position on choice of agents among TNF inhibitors].

Z Rheumatol. 2005 Mar;64(2):88-9. doi: 10.1007/s00393-005-0708-6.

[Internist's therapy of rheumatoid arthritis].

Internist (Berl). 2004 Jun;45(6):693-705; quiz 706. doi: 10.1007/s00108-004-1208-5.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

[Revised recommendations of the Deutsche Gesellschaft für Rheumatologie on therapy with tumor necrosis factor-inhibiting active substances on inflammatory diseases].

作者信息

Manger B

机构信息

Medinizische Klinik III, Krankenhausstr. 12, 91054 Erlangen.

出版信息

Z Rheumatol. 2002 Dec;61(6):694-7. doi: 10.1007/s00393-002-0451-1.

DOI:10.1007/s00393-002-0451-1

PMID:12491133

Abstract

摘要